Your browser is no longer supported. Please, upgrade your browser.
MNK Mallinckrodt Public Limited Company daily Stock Chart
Mallinckrodt Public Limited Company
Index- P/E1.70 EPS (ttm)12.84 Insider Own0.80% Shs Outstand82.75M Perf Week4.86%
Market Cap1.80B Forward P/E2.97 EPS next Y7.35 Insider Trans0.15% Shs Float81.59M Perf Month9.00%
Income1.18B PEG0.12 EPS next Q1.92 Inst Own- Short Float30.03% Perf Quarter-29.80%
Sales2.64B P/S0.68 EPS this Y902.60% Inst Trans1.10% Short Ratio11.84 Perf Half Y-32.75%
Book/sh79.37 P/B0.27 EPS next Y3.52% ROA11.30% Target Price29.00 Perf Year35.05%
Cash/sh3.51 P/C6.21 EPS next 5Y14.00% ROE26.40% 52W Range11.65 - 36.65 Perf YTD38.04%
Dividend- P/FCF2.86 EPS past 5Y148.40% ROI12.60% 52W High-40.49% Beta2.28
Dividend %- Quick Ratio2.10 Sales past 5Y13.50% Gross Margin50.40% 52W Low87.21% ATR0.78
Employees3900 Current Ratio2.20 Sales Q/Q6.60% Oper. Margin6.20% RSI (14)58.39 Volatility2.98% 3.67%
OptionableYes Debt/Eq0.94 EPS Q/Q121.40% Profit Margin65.20% Rel Volume0.52 Prev Close21.78
ShortableYes LT Debt/Eq0.93 EarningsFeb 26 BMO Payout0.00% Avg Volume2.07M Price21.81
Recom2.80 SMA202.40% SMA509.77% SMA200-7.18% Volume1,078,454 Change0.14%
Nov-19-18Upgrade Canaccord Genuity Hold → Buy $34 → $40
Sep-11-18Downgrade Goldman Neutral → Sell
Aug-24-18Reiterated B. Riley FBR Neutral $20 → $37
Aug-08-18Reiterated Stifel Hold $18 → $30
Aug-08-18Downgrade Raymond James Outperform → Mkt Perform
May-09-18Reiterated Barclays Underweight $20 → $12
May-02-18Initiated B. Riley FBR, Inc. Neutral $15
Mar-09-18Reiterated Mizuho Neutral $21 → $16
Feb-02-18Downgrade Barclays Equal Weight → Underweight $23 → $20
Jan-09-18Reiterated Mizuho Neutral $22 → $21
Jan-03-18Initiated Leerink Partners Mkt Perform $26
Nov-08-17Reiterated Canaccord Genuity Buy $38 → $24
Nov-08-17Downgrade Wells Fargo Outperform → Market Perform
Nov-08-17Downgrade Goldman Buy → Neutral
Nov-08-17Downgrade Barclays Overweight → Equal Weight $65 → $23
Nov-07-17Downgrade Deutsche Bank Buy → Hold $44 → $28
Sep-28-17Initiated Goldman Buy $55
Sep-06-17Downgrade Morgan Stanley Overweight → Equal-Weight
Jun-16-17Initiated Cantor Fitzgerald Overweight $52
May-09-17Reiterated Canaccord Genuity Buy $91 → $87
Feb-15-19 04:08PM  What's in the Cards for Bausch Health (BHC) Q4 Earnings? Zacks
Feb-13-19 09:30AM  MNK vs. AMPH: Which Stock Should Value Investors Buy Now? Zacks
Feb-12-19 06:55AM  Mallinckrodt To Present At Barclays Global Healthcare Conference PR Newswire
Feb-11-19 03:58PM  Is a Disappointment in Store for Incyte (INCY) Q4 Earnings? Zacks
Feb-08-19 05:13PM  Teva (TEVA) to Report Q4 Earnings: What's in the Cards? Zacks
04:56PM  Tilray (TLRY) to Report Q4 Earnings: What's in the Cards? Zacks
Feb-07-19 04:31PM  Exelixis (EXEL) to Report Q4 Earnings: What's in Store? Zacks
07:36AM  6 Low Price-to-Book Value Stocks to Buy in February Zacks
Feb-05-19 10:10AM  Why Mallinckrodt (MNK) Could Beat Earnings Estimates Again Zacks
06:55AM  Mallinckrodt Provides Update on Phase 4 Data H.P. Acthar® Gel (Repository Corticotropin Injection) Clinical Trial in Patients with Rheumatoid Arthritis (RA) PR Newswire
Feb-04-19 03:41PM  Dr. Reddy's (RDY) Earnings and Revenues Improve Y/Y in Q3 Zacks
Feb-03-19 10:58PM  [$$] Want to Invest in a True Value Fund? Good Luck Finding One The Wall Street Journal
10:11PM  [$$] Want to Invest in a True 'Value' Fund? Good Luck Finding One The Wall Street Journal
Feb-01-19 05:58PM  Mylan's Generic Version of Advair Diskus Wins FDA Approval Zacks
Jan-28-19 09:30AM  MNK vs. AMPH: Which Stock Should Value Investors Buy Now? Zacks
Jan-24-19 11:55AM  Goldman Sachs is worried about these stocks heading into their earnings reports CNBC
Jan-23-19 09:05AM featured expert Kevin Matras highlights: Mallinckrodt Public, Dell Technologies, American Axle & Manufacturing, Magna International and General Motors Zacks
Jan-22-19 06:27AM  6 Promising Price-to-Book Value Stocks With Solid Prospects Zacks
Jan-16-19 05:06PM  5 Health Care Stocks in Gurus' Portfolios
Jan-14-19 12:09PM  House Democrats launch drug-pricing probe into a dozen major health-care companies CNBC
12:03PM  The Mallinckrodt Spinoff Is a Short-Term Win
06:45AM  Mallinckrodt plc To Report Earnings Results For Fourth Quarter And Fiscal 2018 PR Newswire
Jan-11-19 09:30AM  MNK vs. AMPH: Which Stock Should Value Investors Buy Now? Zacks
Jan-10-19 02:54PM  Akorn (AKRX) Gets FDA Warning Letter for Illinois Facility Zacks
Jan-03-19 05:43PM  Cara (CARA) Up on IDMC's Recommendation to Continue Trial Zacks
06:30AM  Data on Use of Mallinckrodt's H.P. Acthar® Gel (Repository Corticotropin Injection) in Patients with Rare Cause of Nephrotic Syndrome Published in Transplantation PR Newswire
Jan-02-19 06:58AM  Heron Gains on Priority Review Designation for Pain Drug Zacks
Dec-24-18 09:29AM  Mallinckrodt's Inhaled Xenon Gas Therapy Enters Phase III Zacks
Dec-21-18 06:45AM  Mallinckrodt And NPXe Announce First Patient Enrolled In Phase 3 Trial Of Inhaled Xenon Gas Therapy PR Newswire -8.76%
06:00AM  Year in review: Hospital shakeups, urgent care invasion lead health care news cycle American City Business Journals
Dec-19-18 07:40PM  [$$] Federal Judge Strikes Down New York Tax on Opioid Industry The Wall Street Journal -5.03%
04:30PM  Judge blocks New York from enforcing opioid surcharge on companies Reuters
Dec-17-18 06:30AM  Mallinckrodt To Present At 37th Annual J.P. Morgan Healthcare Conference PR Newswire
Dec-15-18 10:56PM  Is Mallinckrodt Public Limited Company (MNK) A Good Stock To Buy? Insider Monkey
Dec-13-18 09:26AM  Mallinckrodt's Roxicodone Reformulation Gets CRL From FDA Zacks
Dec-12-18 10:17AM  FDA Snubs Mallinckrodt's Abuse-Deterrent Opioid Reformulation Benzinga
07:54AM  FDA declines to approve Mallinckrodt's abuse-deterrent opioid painkiller Reuters
07:45AM  [$$] FDA Doesn't Approve Mallinckrodt's Abuse-Deterrent Roxicodone The Wall Street Journal
06:58AM  Mallinckrodt shares slide 4% premarket after pain treatment approval delayed MarketWatch
06:54AM  FDA declines to approve reformulated Mallinckrodt opioid Reuters
06:45AM  Mallinckrodt's SpecGx LLC Receives FDA Complete Response Letter for Abuse-Deterrent, Immediate-Release Reformulation of Roxicodone® (Oxycodone Hydrochloride) PR Newswire
Dec-07-18 03:14PM  Mallinckrodt (MNK) to Separate Generics & Branded Businesses Zacks
02:25PM  Mallinckrodt company that remains in St. Louis faces big threats American City Business Journals
11:28AM  Investors Hope Cleaving of Mallinckrodt Provides Meaty Returns
Dec-06-18 11:59PM  Mallinckrodt plc -- Moody's: Mallinckrodt's proposed specialty generics spin-off is credit negative Moody's -6.96%
02:29PM  Mallinckrodt to spin off generic drugs business; specialty drugs to be based in New Jersey American City Business Journals
11:37AM  Mallinckrodt to spin off generics business, but to keep options open Reuters
09:07AM  Shares of Mallinckrodt Pharmaceuticals up 0.5% after company announces generics business spin-off MarketWatch
06:13AM  Mallinckrodt plans to spin off specialty generics business Reuters
06:00AM  Mallinckrodt Plans Spin-Off of Specialty Generics Business to Shareholders PR Newswire
Dec-04-18 10:48AM  Is Mallinckrodt Public Limited Company (NYSE:MNK) A Volatile Stock? Simply Wall St.
Nov-26-18 04:08PM  Why Mallinckrodt Stock Sank Today Motley Fool -8.09%
03:59PM  5 Top Stock Trades for Tuesday: GE, GM and Cyber Monday InvestorPlace
02:20PM  Mallinckrodt plc (MNK) Investigated by Block & Leviton LLP For Violations of Federal Securities Laws ACCESSWIRE
Nov-19-18 12:33PM  Mallinckrodt Stock Can Rally Another 27%, Says Analyst
11:15AM  Canaccord Turns Bullish On Mallinckrodt: 4 Reasons Why Benzinga
Nov-16-18 08:08AM  The Daily Biotech Pulse: Mallinckrodt FDA Verdict, European Cheer For Bristol-Myers Squibb, Morphosys Clinches Licensing Deal Benzinga
Nov-15-18 04:09PM  Mallinckrodt Gets FDA Committee Vote for Abuse-Deterrent Drug Zacks
08:45AM  Consolidated Research: 2018 Summary Expectations for Tapestry, Mallinckrodt public limited company, Moxian, Applied Genetic Technologies, VistaGen Therapeutics, and Oasis Midstream Partners LP Fundamental Analysis, Key Performance Indications GlobeNewswire
08:10AM  The Daily Biotech Pulse: FDA Nod For Mallinckrodt's Pain Drug, AbbVie-Neurocrine Report Positive Elagolix Results Benzinga
Nov-14-18 05:08PM  Mallinckrodt's SpecGx LLC Reports on Outcome of FDA Joint Advisory Committee on Abuse-Deterrent, Immediate-Release Reformulation of Roxicodone® (Oxycodone Hydrochloride) PR Newswire
08:17AM  The Daily Biotech Pulse: Mallinckrodt Faces FDA Panel, Reshape's Earnings, Vapotherm To Debut Benzinga
Nov-13-18 12:51PM  Which Pharmaceutical Stocks Are Outperforming All Other Stocks? Investor's Business Daily
Nov-12-18 05:00PM  Mallinckrodt To Present At BMO Prescriptions For Success Healthcare Conference PR Newswire
Nov-09-18 08:09AM  Mallinckrodt Presents Terlipressin Clinical Data at The Liver Meeting® 2018 PR Newswire
Nov-08-18 06:45AM  Mallinckrodt Earns International Standard ISO 13485:2016 and Medical Device Single Audit Program (MDSAP) Certifications for INOmax® DSIR® Plus Nitric Oxide Delivery Systems PR Newswire
Nov-07-18 04:08PM  Mallinckrodt (MNK) Beats on Q3 Earnings Estimates, Ups View Zacks
09:44AM  Company News For Nov 7, 2018 Zacks
06:55AM  Today's Research Reports on Trending Tickers: Mallinckrodt Public Limited and OPKO Health ACCESSWIRE
06:30AM  The Market Is Finally Embracing Long-Unloved Drug Stocks
Nov-06-18 05:21PM  Edited Transcript of MNK earnings conference call or presentation 6-Nov-18 1:30pm GMT Thomson Reuters StreetEvents +9.13%
04:47PM  Mallinckrodt Pops On Quarter Beat As Lilly Dips On Mixed Report Investor's Business Daily
12:38PM  Wall Street Advances on Tuesday
09:30AM  MNK or AMPH: Which Is the Better Value Stock Right Now? Zacks
09:10AM  Should Value Investors Buy Mallinckrodt (MNK) Stock? Zacks
07:55AM  Mallinckrodt (MNK) Surpasses Q3 Earnings and Revenue Estimates Zacks
07:43AM  Stocks making the biggest move premarket: CVS, Eli Lilly, Marriott, Mylan & more CNBC
06:52AM  Mallinckrodt: 3Q Earnings Snapshot Associated Press
06:00AM  Mallinckrodt plc Reports Third Quarter 2018 Results and Raises Earnings Guidance for 2018 PR Newswire
Nov-05-18 01:17PM  Q3 Earnings Preview For Mallinckrodt Benzinga
Nov-02-18 06:45AM  Leading Hepatorenal Expert Joins Mallinckrodt's Scientific Advisory Council PR Newswire
Nov-01-18 09:26AM  Attention Biotech Investors: Mark Your Calendar For These November PDUFA Dates Benzinga +6.94%
Oct-26-18 06:45AM  First Patient Screened in Mallinckrodt Phase 4 Trial of H.P. Acthar® Gel (Repository Corticotropin Injection) for Severe Noninfectious Intermediate Uveitis, Posterior Uveitis, or Panuveitis PR Newswire
Oct-24-18 12:27PM  Republic Services sues Mallinckrodt in wake of EPA plan for landfill American City Business Journals -6.51%
Oct-23-18 04:30PM  Mallinckrodt and the Lupus Foundation of America Present Data from Survey of Over 1,500 Individuals with Self-Reported Lupus at the 2018 American College of Rheumatology/Association of Rheumatology Health Professionals (ACR/ARHP) Annual Meeting PR Newswire
Oct-22-18 06:45AM  Mallinckrodt Presents Data on H.P. Acthar® Gel (Repository Corticotropin Injection) in Rheumatoid Arthritis (RA) at the 2018 American College of Rheumatology/Association of Rheumatology Health Professionals (ACR/ARHP) Annual Meeting PR Newswire
Oct-19-18 09:29AM  Mallinckrodt (MNK) Gets $26 Million as Funding From BARDA Zacks
Oct-16-18 06:45AM  Mallinckrodt To Present At Jefferies London Healthcare Conference PR Newswire
Oct-15-18 06:45AM  Mallinckrodt's Stratatech Company Awarded $26 Million in Additional BARDA Funding for Pediatric Studies of StrataGraft® Skin Tissue in Thermal Burns PR Newswire
Oct-12-18 01:37PM  How St. Louis stocks weathered this weeks tumble American City Business Journals
Oct-09-18 01:04PM  Opioid antidote inventor: We're in the 'next phase of this opioid crisis' Yahoo Finance
Oct-08-18 06:28PM  Generic-Drugs Stock Outlook: No Respite from Pricing Issues Zacks
06:45AM  U.S. FDA Announces Joint Advisory Committee Review of Mallinckrodt's Abuse-Deterrent, Immediate-Release Reformulation of Roxicodone® (Oxycodone Hydrochloride) PR Newswire
Oct-05-18 03:38PM  Q&A: Synthetic blood startup's new CEO hopes to bring product to hospitals, battlefields and eventually Mars American City Business Journals
12:15PM  Jefferies: Reaction In Mallinckrodt Shares To Praxair Competition Overblown Benzinga
08:00AM  Today's Research Reports on Trending Tickers: Eli Lilly and Company and Mallinckrodt ACCESSWIRE
Oct-04-18 05:26PM  Today's market winners & losers Yahoo Finance Video -17.29%
04:32PM  Why Mallinckrodt, International Speedway, and LGI Homes Slumped Today Motley Fool
Oct-02-18 09:30AM  MNK or AMPH: Which Is the Better Value Stock Right Now? Zacks
Sep-28-18 09:59AM  Forget Mylan, Invest in These 3 Generic/Drug Stocks Instead Zacks
Mallinckrodt public limited company develops, manufactures, markets, and distributes branded pharmaceutical products in Canada and the European Union, as well as in Latin American, the Middle Eastern, African, and the Asia-Pacific regions. The company markets branded pharmaceutical products for autoimmune and rare diseases in the specialty areas of neurology, rheumatology, nephrology, ophthalmology, and pulmonology; and immunotherapy and neonatal respiratory critical care therapies, as well as analgesics and gastrointestinal products. It offers H.P. Acthar Gel, an injectable drug for various indications, such as proteinuria, multiple sclerosis, infantile spasms, ophthalmic, neuromuscular disorders, dermatomyositis, polymyositis, rheumatology, and pulmonology; Inomax, a vasodilator to enhance oxygenation and reduce the need for extracorporeal membrane oxygenation; Ofirmev, an intravenous formulation of acetaminophen for pain management; Therakos, an immunotherapy treatment platform; and Amitiza for the treatment of chronic idiopathic constipation. The company is also developing StrataGraft, which is in Phase III and II clinical development for the treatment of burns; terlipressin for the treatment of hepatorenal syndrome; MNK-1411 for the treatment of Duchenne muscular dystrophy; Stannsoporfin, a heme oxygenase inhibitor for the treatment of jaundice; Xenon gas for inhalation; MNK-6105, an ammonia scavenger for the treatment of hepatic encephalopathy, a neuropsychiatric syndrome associated with hyperammonemia; VTS-270 that is in Phase III development for Niemann-Pick Type C, a neurodegenerative fatal disease; and CPP-1X/sulindac, which is in Phase III development for Familial Adenomatous Polyposis. Mallinckrodt public limited company markets its branded products to physicians, pharmacists, pharmacy buyers, hospital procurement departments, ambulatory surgical centers, and specialty pharmacies. The company is based in Staines-Upon-Thames, the United Kingdom.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Trudeau MarkPresident and CEODec 10Buy20.181,00020,180236,254Dec 11 08:30 AM
Trudeau MarkPresident and CEOMay 16Buy15.543,00046,615269,961May 18 04:46 PM
Flynn James E10% OwnerMay 09Sale13.39312,9284,189,8188,308,455May 10 04:51 PM